US Patent Issued to UNIVERSIDADE DE SANTIAGO DE COMPOSTELA, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE D'ANGERS on May 26 for "Small extracellular vesicles expressing a dominant negative AMPK alpha 1 mutant for use in the treatment of obesity" (French, Spanish Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,660, issued on May 26, was assigned to UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, Spain), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (Paris) and UNIVERSITE D'ANGERS (Angers, France).

"Small extracellular vesicles expressing a dominant negative AMPK alpha 1 mutant for use in the treatment of obesity" was invented by Edward Milbank (Santiago de Compostela, Spain), Miguel Antonio Lopez Perez (Santiago de Compostela, Spain), Maria Del Carmen Martinez Martinez (Paris) and Ramaroson Andriantsitohaina (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office:...